FDA recall Z-1903-2021

BioFire Diagnostics, LLC · Class II · device

Product

BioFire BCID2 Panel, REF RFIT-ASY-0147, For FilmArray Systems, CE, Blood Culture Identification Panel in vitro diagnostic, Rx Only, UDI: (01)00815381020338

Reason for recall

Elevated rates of false negative results may occur when using blood culture panels due to issues in the manufacturing process. Pouches contained OPP from FilmArray Blood Culture Identification Panel (BCID) instead of OPP from BCID2 Panel.

Distribution

US nationwide distribution

Key facts

Status
Terminated
Initiation date
2021-05-10
Report date
2021-06-30
Termination date
2022-12-15
Voluntary/Mandated
Voluntary: Firm initiated
Location
Salt Lake City, UT, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1903-2021